Trial
NCT02442752
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Takeda
Collaborators
—
Condition
Pediatric Gastroesophageal Reflux Disease
Intervention
Dexlansoprazole
Why stopped
Withdrawn: Business decision (no enrollment)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-15